Quality of Life Measurement for Lymphedema Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034664

Enrollment

200

Registered

2024-07-16

Start date

2023-10-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I89.01 I89.02 I89.03

Interventions

Group 1: Patients with lymphedema of the upper extremity are interviewed once as part of this cross-sectional study. Quality of life is assessed overall with the SF-36 questionnaire and in specific as

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Medically diagnosed lymphedema and the participant's ability to provide. Informed consent.

Exclusion criteria

Exclusion criteria: Missing consent. No medically diagnosed lymphedema.

Design outcomes

Primary

Measure	Time frame
gender, primary or secondary cause, the affected side, employment status, educational attainment, smoking status, ISL stage, age, the time between diagnosis and interview, and BMI	—

Secondary

Measure	Time frame
LYMQOL Questionnaire Function - subscale Appearance- subscale Symptoms- subscale Mood- subscale LYMQOL score SF-36 Questionnaire: General health (GH)- subscale Physical function (PF)- subscale Role physical (RP)- subscale Role emotional (RE)- subscale Vitality (VT) - subscale Mental health (MH) - subscale Social functioning (SF) - subscale Bodily pain (BP) - subscale	—

Countries

Germany

Contacts

Public ContactStefan Langer

Uniklinikum Leipzig

stefan.langer@medizin.uni-leipzig.de0341 97-109

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026